Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot
Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot
View: Text | PDF
Article Immunology

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

  • Text
  • PDF
Abstract

Research Article

Authors

Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Effect of various synthetic RNA motifs on specific antibody and T cell i...
Effect of various synthetic RNA motifs on specific antibody and T cell immunity. (a) The impact of various RNA pools (see Table 1) on adaptive immunity was measured in C57BL/6 mice coimmunized with OVA via the respiratory tract. Mice were immunized intratracheally, followed by two boosts 2 weeks apart by intranasal instillation. The antibody response was expressed as mean ± SEM of IgG endpoint titers (n = 4/group). As controls, we used dose-matched OVA in sterile PBS, OVA with CTB, and PBS alone, respectively. (b) Effect of various dsRNA motifs on the induction of antibody response to OVA; results are expressed as in a. The data are representative of two independent experiments. Inset: the ratio of mean IgG2a and IgG1 titers to OVA. The order from left to right is similar to that in the larger graph: PBS OVA, CTB OVA, pC:pG OVA, pI:pC OVA, and pA:pU OVA. (c) Magnitude and profile of T cell response induced by OVA together with various dsRNA motifs in female C57BL/6 mice. The results obtained by ELISpot analysis were expressed as mean ± SEM of the number of IFN-γ and IL-4 spot-forming colonies (SFCs) per spleen (n = 4/group). The results are representative of two independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts